| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |